Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | RPTOR | Q8N122 | 1/20 | 0.40 |
| ▸ | MLST8 | Q9BVC4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22594371 | 0.83 | HPGDS (0.49) | NAMPTMTORALDH1A1NPC1RAB9A | |
| SCHEMBL23507791 | 0.78 | KDM1A (0.44) | NAMPTKDM1AMAOAMAOBMTOR | |
| SCHEMBL15813925 | 0.78 | NAMPT (0.43) | NAMPTKDM1AMAOAMAOBMTOR | |
| SCHEMBL21067338 | 0.75 | NAMPT (0.52) | NAMPTKDM1AMAOAMAOBALDH1A1 | |
| SCHEMBL1990298 | 0.75 | MTOR (0.52) | MTORRPTORMLST8ALDH1A1GRM4 | |
| SCHEMBL20729411 | 0.74 | KCNH3 (0.41) | NAMPTKDM1AMAOAMAOBALDH1A1 | |
| SCHEMBL29664287 | 0.74 | DRD2 (0.46) | NAMPTKDM1AMAOAMAOBALDH1A1 | |
| SCHEMBL90440 | 0.70 | ALDH1A1 (0.56) | ALDH1A1NPC1RAB9A | |
| SCHEMBL24409334 | 0.69 | ALDH1A1 (0.53) | MTORRPTORMLST8ALDH1A1NPC1 | |
| SCHEMBL27330093 | 0.69 | KMT2A (0.45) | ALDH1A1POLBNOTUMMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10342781-B2 | Diazole amides | CHEMOCENTRYX, INC. (US) | 2019-07-09 | — | — | US | disclosed |
| US-10342781-B2 | Diazole amides | CHEMOCENTRYX, INC. (US) | 2019-07-09 | — | — | US | disclosed |
| US-20180071257-A1 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. | 2018-03-15 | — | — | US | disclosed |
| US-20180071257-A1 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. | 2018-03-15 | — | — | US | disclosed |
| US-9750722-B2 | Diazole amides | CHEMOCENTRYX, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-9750722-B2 | Diazole amides | CHEMOCENTRYX, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-20160193185-A1 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. | 2016-07-07 | — | — | US | disclosed |
| US-20160193185-A1 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. | 2016-07-07 | — | — | US | disclosed |
| EP-2935227-A2 | DIAZOLE AMIDES | ChemoCentryx, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| US-9169248-B2 | Diazole amides | CHEMOCENTRYX, INC. (US) | 2015-10-27 | — | — | US | disclosed |
| US-9169248-B2 | Diazole amides | CHEMOCENTRYX, INC. (US) | 2015-10-27 | — | — | US | disclosed |
| US-20140179733-A1 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| US-20140179733-A1 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| WO-2014100735-A2 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. (US) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014100735-A2 | DIAZOLE AMIDES | CHEMOCENTRYX, INC. (US) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180071257-A1 | DIAZOLE AMIDES | CCR1, CCRL2, CCR4 | NAMPT 1818/4885KDM1A 2395/4885MAOA 4784/4885 |
| US-10342781-B2 | Diazole amides | CCR1, CCRL2, CCR4 | NAMPT 1818/4885KDM1A 2395/4885MAOA 4784/4885 |
| US-20140179733-A1 | DIAZOLE AMIDES | CCR1, CCRL2, CCR4 | NAMPT 1818/4885KDM1A 2395/4885MAOA 4784/4885 |
| US-20160193185-A1 | DIAZOLE AMIDES | CCR1, CCRL2, CCR4 | NAMPT 1818/4885KDM1A 2395/4885MAOA 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.